Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	NF-kappa B signaling pathway	6/104	7.933426225711089e-10	3.2130376214129914e-08	121.98979591836735	-343.35038043058773	CXCL2;IKBKG;IRAK4;MYD88;NFKB1;NFKBIA
KEGG_2021_Human	Toll-like receptor signaling pathway	6/104	7.933426225711089e-10	3.2130376214129914e-08	121.98979591836735	-343.35038043058773	IKBKG;IRAK4;MYD88;NFKB1;NFKBIA;TLR3
KEGG_2021_Human	Hepatitis B	6/162	1.1657637504621833e-08	3.147562126247895e-07	76.07692307692308	-238.99790749378803	IKBKG;IRAK4;MYD88;NFKB1;NFKBIA;TLR3
KEGG_2021_Human	Influenza A	6/172	1.671886438631681e-08	3.3855700382291545e-07	71.40361445783132	-227.05657761700246	IKBKG;IRAK4;MYD88;NFKB1;NFKBIA;TLR3
KEGG_2021_Human	NOD-like receptor signaling pathway	6/181	2.2716519598648245e-08	3.680076174981016e-07	67.65428571428572	-217.27332348682836	CXCL2;IKBKG;IRAK4;MYD88;NFKB1;NFKBIA
KEGG_2021_Human	Chagas disease	5/102	6.972006864965533e-08	8.067607943745832e-07	82.17525773195877	-227.56322024445333	IKBKG;IRAK4;MYD88;NFKB1;NFKBIA
KEGG_2021_Human	Lipid and atherosclerosis	6/215	6.372447911498552e-08	8.067607943745832e-07	56.40430622009569	-186.7350241167357	CXCL2;IKBKG;IRAK4;MYD88;NFKB1;NFKBIA
KEGG_2021_Human	Coronavirus disease	6/232	1.0038183269047773e-07	1.0053988902642704e-06	52.04867256637168	-174.3857646205266	IKBKG;IRAK4;MYD88;NFKB1;NFKBIA;TLR3
KEGG_2021_Human	Toxoplasmosis	5/112	1.1171098780714114e-07	1.0053988902642704e-06	74.40186915887851	-210.55667833010622	IKBKG;IRAK4;MYD88;NFKB1;NFKBIA
KEGG_2021_Human	Yersinia infection	5/137	3.070399768694536e-07	2.4309207757297e-06	60.121212121212125	-177.50304940933535	IKBKG;IRAK4;MYD88;NFKB1;NFKBIA
KEGG_2021_Human	Measles	5/139	3.301250436176135e-07	2.4309207757297e-06	59.208955223880594	-175.30198917758304	IKBKG;IRAK4;MYD88;NFKB1;NFKBIA
KEGG_2021_Human	Legionellosis	4/57	4.533460591014752e-07	3.060085898934958e-06	100.81761006289308	-216.95395722754864	CXCL2;MYD88;NFKB1;NFKBIA
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	4/70	1.044163095458912e-06	6.505939287090144e-06	80.82828282828282	-183.98664919066243	CXCL2;IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	Leishmaniasis	4/77	1.5346775084568718e-06	8.87920558464333e-06	73.01369863013699	-170.21630123625883	IRAK4;MYD88;NFKB1;NFKBIA
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	5/193	1.6904863123009375e-06	9.128626086425062e-06	41.91489361702128	-131.10253044151457	CXCL2;IKBKG;NFKB1;NFKBIA;TLR3
KEGG_2021_Human	Pathogenic Escherichia coli infection	5/197	1.8711461538037305e-06	9.472677403631386e-06	41.020833333333336	-128.67211865204692	IKBKG;IRAK4;MYD88;NFKB1;NFKBIA
KEGG_2021_Human	Epstein-Barr virus infection	5/202	2.1180989596916704e-06	1.0092118572648547e-05	39.954314720812185	-125.75142714199099	IKBKG;IRAK4;MYD88;NFKB1;NFKBIA
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	4/89	2.7491085630604124e-06	1.1719883874099654e-05	62.61176470588235	-150.9687540546772	IKBKG;MYD88;NFKB1;NFKBIA
KEGG_2021_Human	Human immunodeficiency virus 1 infection	5/212	2.6891423738912685e-06	1.1719883874099654e-05	37.97584541062802	-120.26946900483341	IKBKG;IRAK4;MYD88;NFKB1;NFKBIA
KEGG_2021_Human	IL-17 signaling pathway	4/94	3.423271653145718e-06	1.3864250195240158e-05	59.096296296296295	-144.19803777501954	CXCL2;IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	Salmonella infection	5/249	5.936720067831368e-06	2.289877740449242e-05	32.0655737704918	-103.35956009638306	IKBKG;IRAK4;MYD88;NFKB1;NFKBIA
KEGG_2021_Human	TNF signaling pathway	4/112	6.897261761044327e-06	2.5394463756572296e-05	49.135802469135804	-124.17448810278691	CXCL2;IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	Herpes simplex virus 1 infection	6/498	9.044529937904887e-06	3.185247499870852e-05	23.097560975609756	-82.2468690367685	IKBKG;IRAK4;MYD88;NFKB1;NFKBIA;TLR3
KEGG_2021_Human	Hepatitis C	4/157	2.633008128708365e-05	8.886402434390732e-05	34.4880174291939	-91.97557482769783	IKBKG;NFKB1;NFKBIA;TLR3
KEGG_2021_Human	Cytosolic DNA-sensing pathway	3/63	5.21817057256637e-05	0.0001690687265511504	57.2	-103.63746645388204	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	Chemokine signaling pathway	4/192	5.8071760943932126e-05	0.00018091587063301932	27.94326241134752	-76.22501680035803	CXCL2;IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	Adipocytokine signaling pathway	3/69	6.857856994284154e-05	0.00020573570982852465	51.96103896103896	-96.07609532933417	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	RIG-I-like receptor signaling pathway	3/70	7.160249860764975e-05	0.00020713579954355823	51.17910447761194	-94.92366080084827	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	Pertussis	3/76	9.159620399517935e-05	0.00024730975078698426	46.93737769080235	-88.55605413655218	IRAK4;MYD88;NFKB1
KEGG_2021_Human	Chronic myeloid leukemia	3/76	9.159620399517935e-05	0.00024730975078698426	46.93737769080235	-88.55605413655218	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	B cell receptor signaling pathway	3/81	0.0001108038559822632	0.00028951975272784904	43.9010989010989	-83.87028294601303	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	Small cell lung cancer	3/92	0.00016192103282048912	0.0003857530487782241	38.42215088282504	-75.11644417571499	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	Th1 and Th2 cell differentiation	3/92	0.00016192103282048912	0.0003857530487782241	38.42215088282504	-75.11644417571499	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	Shigellosis	4/246	0.00015252097444894315	0.0003857530487782241	21.55922865013774	-59.801482853342776	IKBKG;MYD88;NFKB1;NFKBIA
KEGG_2021_Human	Prostate cancer	3/97	0.00018948670381727933	0.0004385263716914179	36.35562310030395	-71.7056117119453	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	T cell receptor signaling pathway	3/104	0.0002329673917108638	0.0005100096953670262	33.806223479490804	-67.40758155759835	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	C-type lectin receptor signaling pathway	3/104	0.0002329673917108638	0.0005100096953670262	33.806223479490804	-67.40758155759835	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	Th17 cell differentiation	3/107	0.0002534260244380865	0.0005401975784075001	32.81868131868132	-65.71442008901244	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	MAPK signaling pathway	4/294	0.0003034351122757725	0.0006302113870342967	17.880459770114943	-49.762697732575255	IKBKG;IRAK4;MYD88;NFKB1
KEGG_2021_Human	Neurotrophin signaling pathway	3/119	0.0003468783323520502	0.0007024286230129016	29.379310344827587	-59.68521503911596	IRAK4;NFKB1;NFKBIA
KEGG_2021_Human	Osteoclast differentiation	3/127	0.0004201187826005964	0.0008299907656255684	27.456221198156683	-56.21805005538481	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	Apoptosis	3/142	0.0005829830335043062	0.001124324421758305	24.447070914696813	-50.640785217242495	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	Tuberculosis	3/180	0.0011634285381276748	0.0021915746881009685	19.106537530266344	-40.222430877266724	IRAK4;MYD88;NFKB1
KEGG_2021_Human	Viral carcinogenesis	3/203	0.0016469262374030193	0.003031841482491922	16.86	-35.61063787888018	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	3/219	0.0020484263518845244	0.0036871674333921437	15.579365079365079	-32.91284230349772	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	Human cytomegalovirus infection	3/225	0.00221350447353219	0.003897692659915378	15.146718146718147	-31.989452913184095	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	Acute myeloid leukemia	2/67	0.002921615714870147	0.005035124955414508	30.78076923076923	-39.02900444511024	IKBKG;NFKB1
KEGG_2021_Human	Pancreatic cancer	2/76	0.0037436519554145367	0.006317412674762031	27.006756756756758	-34.90410589940028	IKBKG;NFKB1
KEGG_2021_Human	Amoebiasis	2/102	0.006650847322673755	0.010774372662731485	19.92	-26.61700675496218	CXCL2;NFKB1
KEGG_2021_Human	Human papillomavirus infection	3/331	0.006599251035795172	0.010774372662731485	10.113240418118467	-20.757683091358754	IKBKG;NFKB1;TLR3
KEGG_2021_Human	Insulin resistance	2/108	0.007430876215757518	0.011801979872085469	18.778301886792452	-25.204052222837845	NFKB1;NFKBIA
KEGG_2021_Human	Relaxin signaling pathway	2/129	0.010471317399144716	0.016311090564052347	15.631889763779528	-21.1770620526928	NFKB1;NFKBIA
KEGG_2021_Human	Fluid shear stress and atherosclerosis	2/139	0.012084353093672291	0.018468539633725578	14.472627737226277	-19.639406588988233	IKBKG;NFKB1
KEGG_2021_Human	Pathways in cancer	3/531	0.02393281759639253	0.0358992263945888	6.12012987012987	-11.164029011261546	IKBKG;NFKB1;NFKBIA
KEGG_2021_Human	cAMP signaling pathway	2/216	0.027803609837697526	0.04094713448824545	9.175233644859814	-12.174459052502558	NFKB1;NFKBIA
KEGG_2021_Human	Ras signaling pathway	2/232	0.03174764714886429	0.04592070391175014	8.519565217391305	-11.194266119915625	IKBKG;NFKB1
KEGG_2021_Human	African trypanosomiasis	1/37	0.04489527895199197	0.06379855430019911	24.790123456790123	-13.876145105511855	MYD88
KEGG_2021_Human	Primary immunodeficiency	1/38	0.046083072411820386	0.06435739423030089	24.117117117117118	-13.560364723090352	IKBKG
KEGG_2021_Human	Malaria	1/50	0.060233261208856796	0.07998187144126886	18.183673469387756	-10.63265628196324	MYD88
KEGG_2021_Human	Cocaine addiction	1/49	0.05906133610748362	0.07998187144126886	18.564814814814813	-10.829316375605623	NFKB1
KEGG_2021_Human	Cholesterol metabolism	1/50	0.060233261208856796	0.07998187144126886	18.183673469387756	-10.63265628196324	APOE
KEGG_2021_Human	PI3K-Akt signaling pathway	2/354	0.06828569708469599	0.08921195909452219	5.480113636363637	-6.479364551821025	IKBKG;NFKB1
KEGG_2021_Human	Alzheimer disease	2/369	0.07347088540357372	0.09446256694745192	5.2459128065395095	-6.1057863985118	APOE;NFKB1
KEGG_2021_Human	Inflammatory bowel disease	1/65	0.07765521083230079	0.09828237620963069	13.895833333333334	-8.322075559905016	NFKB1
KEGG_2021_Human	Prolactin signaling pathway	1/70	0.08339759626885078	0.10392623535041405	12.880837359098228	-7.74542097629872	NFKB1
KEGG_2021_Human	Rheumatoid arthritis	1/93	0.1094003568916107	0.1342640743669768	9.632850241545894	-5.8073541800756905	CXCL2
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	1/100	0.11718138394436346	0.13958370734549178	8.94388327721661	-5.375723879218761	NFKB1
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	1/100	0.11718138394436346	0.13958370734549178	8.94388327721661	-5.375723879218761	CXCL2
KEGG_2021_Human	Longevity regulating pathway	1/102	0.11939326812281527	0.1401573147528701	8.764576457645765	-5.262086311101535	NFKB1
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.14706781291092091	8.189300411522634	-4.893732148578802	NFKB1
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.15742961932193836	7.4858757062146895	-4.435243302362896	NFKB1
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.1966865920901397	5.672401433691756	-3.209640069203435	NFKB1
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.17622102470306392	0.1966865920901397	5.70995670995671	-3.235678410841787	NFKB1
KEGG_2021_Human	Necroptosis	1/159	0.18037286671285227	0.19743516491541938	5.562587904360056	-3.1333425612983894	TLR3
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.2277896170828007	4.657210401891253	-2.4954112144854435	NFKB1
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.21391358807496763	0.2279868504483208	4.5823152995927865	-2.441961042053517	NFKB1
KEGG_2021_Human	Diabetic cardiomyopathy	1/203	0.22481613944093093	0.2364948999313689	4.326732673267327	-2.2588473265567357	NFKB1
KEGG_2021_Human	Chemical carcinogenesis	1/239	0.2595523897792453	0.26953517400152394	3.6554621848739495	-1.7734497985532327	NFKB1
KEGG_2021_Human	Cytokine-cytokine receptor interaction	1/295	0.310808292768788	0.3186768571426814	2.9380196523053668	-1.2513063817932166	CXCL2
KEGG_2021_Human	MicroRNAs in cancer	1/310	0.3239838755949599	0.3280336740398969	2.7900035958288387	-1.143955577607994	NFKB1
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.45466905008847364	0.45466905008847364	1.7801218940459447	-0.4367315309409891	NFKB1
